SOURCE: Smith & Nephew PLC

September 16, 2009 04:00 ET

Smith&Nephew-Global Launch Allevyn Range Extension

LONDON--(Marketwire - September 16, 2009) -


Smith & Nephew announces the global launch of new ALLEVYN* Ag Gentle
and ALLEVYN Ag Gentle Border antimicrobial dressings

HULL, UK 16 September 2009 - Smith & Nephew's (LSE: SN; NYSE:SNN)
Advanced Wound Management division, announced today that it is
launching two extensions to the ALLEVYN Ag range of dressings; ALLEVYN
Ag Gentle Border and ALLEVYN Ag Gentle. These dressings will combine
the antimicrobial protection of silver with the gentleness of silicone
and soft gel adhesives that have been specifically designed to minimise
pain to the patient and trauma to the wound at dressing removal.

These two new exciting ALLEVYN Ag variants are available in a range of
sizes and offer patients living with a wound and clinicians three key
benefits: antimicrobial protection to help fight infection; minimal
pain on removal at dressing change and superior fluid management thanks
to the unique triple action technology of ALLEVYN.

Roger Teasdale, President, Smith & Nephew Advanced Wound Management,
said, "The addition of these two new ALLEVYN Ag variants will
undoubtedly add to the growing success of ALLEVYN and will enable us to
maintain our position as the leading global brand within the foam
dressings market. ALLEVYN Ag Gentle Border provides the perfect
opportunity to reinforce the perception of Smith & Nephew as leading
the way in woundcare as we will be the first company to offer an
adhesive bordered silicone silver product which combines the benefits
of silver and silicone gel technology. I am pleased that we have been
able to enhance the ALLEVYN Ag range in a way which offers additional
benefits and choice to our customers and which will continue to improve
the quality of life for patients living with a wound."

It was encouraging to note that these new additions were
enthusiastically greeted by US clinicians following their recent
launch: "An innovative new dressing which provides antimicrobial
protection, as well as the ability to remove and re-apply without
disruption of the wound base, which is suitable for many types of
wounds especially skin tears" Paula Kotz, BSN, RN, C, CWOCN, E.T.
Consultant Services Inc., Asheville, NC.

The launch of ALLEVYN Ag Gentle and ALLEVYN Ag Gentle Border means that
we now offer a complete range of foam dressings for infected as well as
non infected wounds and are in the unique position of being able to
provide a clinically proven and cost effective solution for all
customers foam dressing needs.

For more information regarding Smith & Nephew, please visit our Web
site at

Sidonie Myers
Head of Communication
Smith & Nephew Advanced Wound Management
+44 (0) 1482 673246

Investors and Analysts
Phil Cowdy
Director Investor Relations
Smith & Nephew
+44 (0) 20 7401 7646

About Smith & Nephew

Smith & Nephew is a global medical technology business, specializing in
Orthopaedics, including Reconstruction, Trauma and Clinical Therapies,
Endoscopy and Advanced Wound Management.  Smith & Nephew is a global
leader in arthroscopy and advanced wound management and is one of the
leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The
Company prides itself on the strength of its relationships with its
surgeons and professional healthcare customers, with whom its name is
synonymous with high standards of performance, innovation and trust.
The Company operates in 32 countries around the world.  Annual sales in
2008 were nearly USD3.8 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within
the meaning of the US Private Securities Litigation Reform Act of 1995.
In particular, statements regarding expected revenue growth and trading
margins discussed under "Outlook" are forward-looking statements as are
discussions of our product pipeline. These statements, as well as the
phrases "aim", "plan", "intend", "anticipate", "well-placed","believe",
"estimate", "expect", "target", "consider" and similar
expressions, are generally intended to identify forward-looking
statements. Such forward-looking statements involve known and unknown
risks, uncertainties and other important factors (including, but not
limited to, the outcome of litigation, claims and regulatory approvals)
that could cause the actual results, performance or achievements of
Smith & Nephew, or industry results, to differ materially from any
future results, performance or achievements expressed or implied by
such forward-looking statements.
Please refer to the documents that Smith & Nephew has filed with the
U.S. Securities and Exchange Commission under the U.S. Securities
Exchange Act of 1934, as amended, including Smith & Nephew's most
recent annual report on Form 20F, for a discussion of certain of these

All forward-looking statements in this press release are based on
information available to Smith & Nephew as of the date hereof. All
written or oral forward-looking statements attributable to Smith &
Nephew or any person acting on behalf of Smith & Nephew are expressly
qualified in their entirety by the foregoing. Smith & Nephew does not
undertake any obligation to update or revise any forward-looking
statement contained herein to reflect any change in Smith & Nephew's
expectation with regard thereto or any change in events, conditions or
circumstances on which any such statement is based.

*Trademark of Smith & Nephew

                    This information is provided by RNS
          The company news service from the London Stock Exchange


Contact Information